Hantaviruses are RNA viruses that are harbored by specific rodent species and are transmitted to man via inhalation of virus-contaminated rodent feces and urine. In the Americas, several hantaviruses are now recognized as etiological agents of hantavirus cardiopulmonary syndrome (HCPS), which has a high case- fatality ratio. Etiologic agents of HCPS are Category A bioweapon threats. Andes virus-associated HCPS in Chile and Argentina is unique among hantaviruses in that it can be transmitted person-to-person. Hantavirus disease was first recognized in the Western Hemisphere in 1993, so there is an urgent need to build expertise in the Americas in rodent ecology, virology, clinical care, and clinical research as it relates to hantavirus infections in the Americas. Our group of U.S. and Chilean investigators has collaborated in hantavirus research, training and technology transfer since 1997, and multiple members of the team contributed to expansion of our research and training to Panama when it experienced its first outbreak of HCPS in 2000. We have had an ICIDR program project grant and a Fogarty ABC training program since 1999, with a track record of successful short- and long-term training of students at multiple levels. In 2004 we obtained supplemental funding through the Global Infectious Disease Research Training Program for a post- doctoral fellowship, and the ICIDR program project grant has been renewed through 2010. In this competitive renewal, our specific aims are to: 1) provide long-term training, including Ph.D., MPH, infectious diseases and critical care and post-doctoral fellowship training at the University of New Mexico, the University of Alabama and Southern Research Institute in areas that will increase the research capacity of the collaborating academic centers in Chile and Panama, 2) provide short-term training at the University of New Mexico, the University of Alabama at Birmingham, the Johns Hopkins University School of Public Health, Catholic University in Santiago, Chile and Universidad del Desarrollo in Santiago, Chile to address specific training needs for the UNM/Chile/Panama ICIDR program, and 3) conduct an annual research and training meeting, jointly supported by this training grant and UNM/Chile/Panama, for team building, to review progress in the research and training activities, for trainees and investigators to report on their projects, and to plan future research and training activities.

National Institute of Health (NIH)
Fogarty International Center (FIC)
International Research Training Grants (D43)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-ICP2-B (50))
Program Officer
Sina, Barbara J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of New Mexico
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Pesko, Kendra N; Torres-Perez, Fernando; Hjelle, Brian L et al. (2010) Molecular epidemiology of Powassan virus in North America. J Gen Virol 91:2698-705
Torres-Perez, Fernando; Wilson, Linda; Collinge, Sharon K et al. (2010) Sin Nombre virus infection in field workers, Colorado, USA. Emerg Infect Dis 16:308-10
Medina, Rafael A; Torres-Perez, Fernando; Galeno, Hector et al. (2009) Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile. J Virol 83:2446-59
Medina, Rafael A; Mirowsky-Garcia, Katy; Hutt, Julie et al. (2007) Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. J Gen Virol 88:493-505
Safronetz, David; Lindsay, Robbin; Hjelle, Brian et al. (2006) Use of IgG avidity to indirectly monitor epizootic transmission of sin nombre virus in deer mice (Peromyscus maniculatus). Am J Trop Med Hyg 75:1135-9
Tager Frey, Marlis; Vial, Pablo C; Castillo, Constanza H et al. (2003) Hantavirus prevalence in the IX Region of Chile. Emerg Infect Dis 9:827-32
Galeno, Hector; Mora, Judith; Villagra, Eliecer et al. (2002) First human isolate of Hantavirus (Andes virus) in the Americas. Emerg Infect Dis 8:657-61